News
A viable alternative in prostate enucleation: PlasmaLEP
Lamidey Noury Medical is a French based factory with over 70 years of surgical expertise in electrosurgery. We proudly manufactured Plasma EDGE, a bipolar plasma resection system designed specifically for TURP and bladder tumour resection. We developed an innovative system...
NOVOGLAN – Conservative Phimosis Management
iMEDicare are pleased to introduce Novoglan, an evidence-based, non-surgical solution for adult phimosis, now available as a reimbursable outpatient treatment under the NHS OPCS-4 code N30.5 (Stretching of the Prepuce), which maps to HRG LB56A. This presents an exciting opportunity...
Nonacus Clinical Services announce partnership with The London Clinic to deliver GALEAS™ Bladder test
Nonacus Clinical Services, the UK laboratory delivering genomic cancer testing services to the NHS and private healthcare providers, recently announced it is working with The London Clinic to help more patients benefit from its non-invasive GALEAS™ Bladder test for cancer....
New CPD Course Advances LATP Biopsy Skills for Clinicians
Mermaid Medical, in collaboration with Fujifilm, recently delivered the first session of a new CPD-accredited training course focused on Local Anaesthetic Transperineal Prostate (LATP) biopsy procedures. Hosted at the advanced Fujifilm House in Bedford, the workshop welcomed healthcare professionals for...
Precision study with the Raypilot ® system now underway
Micropos Medical is a Swedish company developing technology for enhanced radiotherapy cancer treatment. Their Raypilot® System offers accuracy through real-time tumor tracking in prostate cancer radiation treatment. The 2024 Pace-B study showed that SBRT with five sessions is as effective...
Bupa covers accurate PSE prostate cancer blood test
A new era in prostate cancer detection is emerging with the EpiSwitch® PSE blood test, a highly accurate tool that enhances early diagnosis while significantly cutting false positives. Now covered by Bupa as a pre-biopsy test, PSE has demonstrated 94%...
Action Bladder Cancer UK urges health professionals to help raise awareness during Bladder Cancer Awareness Month in May
Action Bladder Cancer UK is calling on health professionals – including specialist urology and cancer nurses, urologists, oncology and radiology health professionals and others, to support Bladder Cancer Awareness Month by helping to raise awareness of the symptoms of bladder...
SIU 2024 B2B GU Cancers Triad Meeting Proceedings
You can now access the SIU 2024 B2B GU Cancers Triad proceedings, published as a supplement to the February issue of SIUJ. Review the latest updates on bladder, kidney and prostate cancers that were presented by expert faculty. Access the...
Rishi Sunak joins Prostate Cancer Research as an ambassador
Rishi Sunak with three prostate cancer patients at the Oxford BioDynamics labs. (From left to right: Dafydd Charles, Briane Milne, Rishi Sunak, Alfred Samuels). Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador, to champion...
Prostate cancer: Black men more likely to be diagnosed at later stages
Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...
Prostate Cancer UK Clinical Champions Programme
Prostate Cancer UK have opened applications for their award-winning Clinical Champions Programme.
Action Bladder Cancer UK offers grants for bladder cancer research
Action Bladder Cancer UK (ABC UK) is inviting applications for grants to support research into bladder cancer, encouraging projects that aim to improve bladder cancer care, treatment, or diagnosis.
